Palliare has secured EU CE Mark approval for its EVA15 insufflator and smoke evacuation system.

The approval has been granted in line with the new EU Medical Devices Regulation (MDR).

Furthermore, the approval of EVA15 establishes it as one of the first laparoscopic and endoscopic insufflators to meet Europe’s more extensive 2021 regulatory requirements for medical devices.

The new system is intended for creating a safer operating room environment while delivering better insufflation and smoke evacuation performance to meet the specific requirements of robotic, endoscopic, endoluminal and laparoscopic procedures.

Designed to deliver similar smoke evacuation and insufflation performance as ConMed’s Airseal system, the EVA15 system also secured approval from the US Food and Drug Administration.

Palliare CEO John O’Dea said: “Certifying EVA15 as a Class 2b device to the new MDR regulation has entailed an extensive exercise, one that puts the company on a firm regulatory approval footing in Europe for the coming years.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We have now started the process of installing EVA15 in leading robotic surgical training centres in Europe.”

Palliare has also reached a group purchasing organisation agreement with New York-based Northwell Health.

Palliare worked with Northwell’s global strategic partnerships team and participated in their international business programme, an initiative designed for international companies to collaborate with the Northwell system.

Palliare was established in 2018 as a spinout from Irish gastro-diagnostic company Crospon, which was taken over by Medtronic in 2017.